Intelligent Bio Solutions Inc. financial data

Symbol
INBS on Nasdaq
Location
135 W 41 St St,, Floor 5, New York, NY
Fiscal year end
June 30
Latest financial report
10-Q - Q1 2025 - May 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 120 % +35.2%
Quick Ratio 14.4 % -9.41%
Debt-to-equity 85.7 % -35.1%
Return On Equity -176 % +16.2%
Return On Assets -93.8 % -4.99%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.91M shares +122%
Common Stock, Shares, Outstanding 6.79M shares +133%
Entity Public Float 5.99M USD +63.3%
Common Stock, Value, Issued 67.9K USD +133%
Weighted Average Number of Shares Outstanding, Basic 5.77M shares +178%
Weighted Average Number of Shares Outstanding, Diluted 5.77M shares +178%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 902K USD -0.61%
Revenue from Contract with Customer, Excluding Assessed Tax 2.94M USD +16.7%
Cost of Revenue 1.21M USD -40%
General and Administrative Expense 8.84M USD -2.04%
Operating Income (Loss) -10.4M USD -1.78%
Nonoperating Income (Expense) 57.1K USD -46.7%
Net Income (Loss) Attributable to Parent -10.3M USD -2.31%
Earnings Per Share, Basic 8 USD/shares +69.2%
Earnings Per Share, Diluted 8 USD/shares +69.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.81M USD -70.1%
Accounts Receivable, after Allowance for Credit Loss, Current 511K USD +18.4%
Inventory, Net 683K USD -22.1%
Other Assets, Current 585K USD +21.7%
Assets, Current 5.11M USD -55.7%
Property, Plant and Equipment, Net 546K USD -2.34%
Operating Lease, Right-of-Use Asset 127K USD -65.3%
Intangible Assets, Net (Excluding Goodwill) 3.8M USD -17.2%
Assets 9.58M USD -43.7%
Employee-related Liabilities, Current 448K USD -32.2%
Accrued Liabilities, Current 607K USD -21.9%
Liabilities, Current 4.56M USD -20%
Operating Lease, Liability, Noncurrent 3.7K USD -97.6%
Liabilities 4.64M USD -23.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -523K USD +21%
Retained Earnings (Accumulated Deficit) -59.4M USD -20.9%
Stockholders' Equity Attributable to Parent 5.11M USD -54.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 4.94M USD -55%
Liabilities and Equity 9.58M USD -43.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.39M USD -82%
Net Cash Provided by (Used in) Financing Activities 42.5K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 6.79M shares +133%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.31M USD -71.4%
Deferred Tax Assets, Valuation Allowance 10.4M USD +9.35%
Deferred Tax Assets, Gross 10.4M USD +9.35%
Operating Lease, Liability 310K USD -39.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.1M USD -0.7%
Lessee, Operating Lease, Liability, to be Paid 335K USD -43.8%
Property, Plant and Equipment, Gross 627K USD -13.4%
Operating Lease, Liability, Current 151K USD -41.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 83.5K USD -73%
Lessee, Operating Lease, Liability, to be Paid, Year One 88K USD -59.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 25.1K USD -70.2%
Additional Paid in Capital 65M USD +6.67%
Amortization of Intangible Assets 936K USD +10.8%
Depreciation, Depletion and Amortization 242K USD -2.41%